"Ne dinim t'i çmontonim ... "Bizneset kanë nevojë për impulse për investime dhe rritje." "Nga ana tjetër, shumë rregulla, përjashtime dhe privilegje duhet të hiqen, sepse ato çojnë ...

Në këtë vend akoma mungon identiteti digjital dhe e gjithë infrastruktura digjitale ka nevojë për investime serioze. Gjermania ka nevojë për investime edhe në infrastruktura të tjera ...

Below is Validea's guru fundamental report for EXELIXIS INC (EXEL). Of the 22 guru strategies we follow, EXEL rates highest using our Multi-Factor Investor model based on the published strategy of ...

Në mbledhjen e mbajtur për Sirinë në Arabinë Saudite është dhënë mbështetje për një proces të tranzicionit politik në Siri që do të realizohet me pjesëmarrjen e segmenteve të ...

Pas marrëveshjes së armëpushimit dhe shkëmbimit të të burgosurve midis Tel Avivit dhe Hamasit, banorët e Gazës kaluan një natë pa ndonjë sulm nga ushtria izraelite dhe u zgjuan pa ...

is now available on the Investors page of the Group’s website (https://www.exel-industries.com/investors-page/?lang=en > Regulated information > Universal ...

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Exelixis (EXEL – Research Report), with a price target of $42.00. The company’s shares closed ...

Boxer Paul Bamba died this week, just days after winning a WBA Cruiserweight title, his manager Ne-Yo said Friday. He was 35. The cause of death was not revealed. The boxer won the WBA Gold ...

Bamba had just won the WBA Gold title on Dec. 21 in New Jersey Paul Bamba/Instagram Championship boxer Paul Bamba has died at 35, his manager Ne-Yo confirmed on Friday, Dec. 27. In a statement ...

The boxing world has lost a champion. Paul Bamba, one of the first boxers to sign with Ne-Yo's management company, died at age 35. "It is with profound sorrow that we announce the passing of ...

Boxer Paul Bamba has tragically passed away just days after winning a WBA cruiserweight rankings belt, his manager Ne-Yo confirmed. The 35-year-old, who was once scheduled to fight Tommy Fury ...

Exelixis (EXEL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. New drug ...